UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Contract Value
Not provided
Codes & Classification
Solicitation Number
ARPA-H-SOL-26-162
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN13
Additional Details
Documents3
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a solicitation for the UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO), identified by procurement number ARPA-H-SOL-26-162. This initiative seeks to advance the UNIQUE Program, which is focused on pioneering research and development in biotechnology, specifically excluding nanobiotechnology, as classified under NAICS code 541714 and Product Service Code AN13.
The primary objective of this procurement is to solicit innovative solutions that leverage quantum entanglement to unify imaging technologies, with the aim of achieving breakthroughs in biomedical imaging and diagnostics. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements as a result of this solicitation, enabling a diverse range of research entities and industry partners to contribute to the program’s ambitious goals.
Interested parties are encouraged to thoroughly review the attached solicitation documents, including UNIQUE-ISO-ARPA-H-SOL-26-162 and related attachments, for detailed requirements and submission guidelines. The scope of work is expected to encompass advanced research, development, and demonstration of novel imaging approaches that utilize quantum entanglement, with deliverables likely including proof-of-concept studies, prototype systems, and comprehensive technical reports.
There are no set-aside requirements for this opportunity, making it accessible to all qualified organizations regardless of size or status. The procurement is classified as a solicitation and is currently active, with a response deadline set for December 16, 2026. Notably, the Proposers’ Day has been rescheduled to October 16, 2026, as per Amendment 01. Potential proposers are advised to consult the separate Special Notice (ARPA-H-SN-26-162) for additional information regarding the Proposers’ Day, which is not attached to this ISO announcement.
All questions submitted in relation to the ISO will be compiled and addressed, with answers posted to the UNIQUE Frequently Asked Questions (FAQ) page. Prospective contractors should monitor this page regularly for updates and clarifications: https://arpa-h.gov/explore-funding/programs/unique/faqs.
The contracting entity for this opportunity is ARPA-H, a federal office within the NIH, with the UNIQUE Team serving as the primary point of contact. Inquiries can be directed to [email protected]. For further details and access to solicitation documents, contractors may visit the official notice page at https://sam.gov/opp/b656f68a72844aa6b6013ad9295625c7/view.
This opportunity represents a significant investment in transformative biotechnology research, offering contractors the chance to participate in a high-impact program with the potential to redefine imaging capabilities in health and medicine. Organizations with expertise in quantum technologies, biomedical imaging, and advanced R&D are strongly encouraged to evaluate their alignment with the UNIQUE Program’s objectives and consider submitting a proposal.